BeyondSpring Interest Expense Over Time

BYSI Stock  USD 1.64  0.07  4.09%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out BeyondSpring Performance and BeyondSpring Correlation.
For more detail on how to invest in BeyondSpring Stock please use our How to Invest in BeyondSpring guide.
  
Interest Expense is expected to grow at the current pace this year.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BeyondSpring. If investors know BeyondSpring will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BeyondSpring listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.40)
Revenue Per Share
0.048
Quarterly Revenue Growth
0.143
Return On Assets
(0.40)
Return On Equity
(3.10)
The market value of BeyondSpring is measured differently than its book value, which is the value of BeyondSpring that is recorded on the company's balance sheet. Investors also form their own opinion of BeyondSpring's value that differs from its market value or its book value, called intrinsic value, which is BeyondSpring's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BeyondSpring's market value can be influenced by many factors that don't directly affect BeyondSpring's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BeyondSpring's value and its price as these two are different measures arrived at by different means. Investors typically determine if BeyondSpring is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BeyondSpring's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Interest Expense Analysis

Compare BeyondSpring and related stocks such as Surrozen, Armata Pharmaceuticals, and Pasithea Therapeutics Interest Expense Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On EquityOperating Cycle
Cash Conversion Cycle
201020112012201320142015201620172018201920202021202220232024
SRZN0.00.00.00.00.00.00.00.00.00.091 K2.1 MM2.2 M1.1 M
ARMP0.0130 K339 K2.9 M0.00.00.00.00.0931 K628 K64 K29 K2.6 M2.8 M
KTTA0.00.00.00.00.00.00.00.00.00.00.0508102117224
ADTX0.00.00.00.00.00.00.00.079.8 K1.9 K310.1 K1.9 M2.3 M6.4 M6.7 M
SCPH326 K326 K326 K326 K326 K326 K6.5 M797 K1.4 M1.8 M2.6 M2.6 M3.3 M8.1 M8.5 M
MIST0.00.00.00.00.00.00.00.00.02.6 M726 K220 K1.3 M2.6 M2.7 M
ONCY0.00.00.00.00.00.00.00.00.00.00.0138.4 K528 K607.2 K637.6 K
MCRB0.00.00.042 K0.0555 K969 K1.6 M1.2 M502 K2.9 M2.9 MM13.2 M13.8 M
KAMMMMMMMMMMM1.3 M3.7 M337 K320.1 K
CADL1.1 M1.1 M1.1 M1.1 M1.1 M1.1 M1.1 M1.1 M1.1 M1.1 M111 K53 K490 K514 K358.1 K
INKT1.6 M1.6 M1.6 M1.6 M1.6 M1.6 M1.6 M1.6 M1.6 M1.6 M2.4 M2.4 M253.3 K228 K216.6 K
FBRX102 K102 K102 K102 K102 K102 K1.8 M1.3 M1.4 M3.8 M0.0222 K17 K15.3 K14.5 K
ALVR0.00.00.00.00.00.00.00.00.00.00.0948 KM3.4 M3.6 M
RVPH0.00.00.00.00.00.00.00.00.0469.4 K1.5 M2.4 K182.8 K164.5 K156.3 K
PLX0.0K554 K674 K4.9 M3.7 M10.7 M9.7 M7.7 MM9.7 M7.5 M2.5 M3.2 M2.8 M
EYPT0.00.00.0K10000.00.0720 K720 K6.2 M7.3 M5.5 M3.2 M1.2 M1.6 M
SLS0.00.033 K807 K1.1 M760 K3.5 M462 K266 K118 K390 K4.4 M649 K746.4 K806.9 K

BeyondSpring and related stocks such as Surrozen, Armata Pharmaceuticals, and Pasithea Therapeutics Interest Expense description

The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.

My Equities

My Current Equities and Potential Positions

BeyondSpring
BYSI
ClassificationCancer Fighters
LocationNew York; U.S.A
ExchangeNASDAQ Exchange
USD 1.64
When determining whether BeyondSpring offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BeyondSpring's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Beyondspring Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Beyondspring Stock:
Check out BeyondSpring Performance and BeyondSpring Correlation.
For more detail on how to invest in BeyondSpring Stock please use our How to Invest in BeyondSpring guide.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
BeyondSpring technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of BeyondSpring technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of BeyondSpring trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...